Prognostic biomarkers in phase II trial of cetuximab-containing induction and chemoradiation in resectable HNSCC: Eastern Cooperative Oncology Group E2303

PURPOSE: We sought to evaluate correlation between tissue biomarker expression (using standardized, quantitative immunofluorescence) and clinical outcome in E2303 trial. EXPERIMENTAL DESIGN: Sixty-three eligible patients with operable stage III/IV HNSCC participated in ECOG 2303, phase II trial of i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Psyrri, Amanda, Lee, Ju-Whei, Pectasides, Eirini, Vassilakopoulou, Maria, Kosmidis, Efstratios K., Burtness, Barbara A., Rimm, David L., Wanebo, Harold J., Forastiere, Arlene A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4049169/
https://ncbi.nlm.nih.gov/pubmed/24700741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-0113
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados